| Elysia Peterson, PT | |
|
11470 Business Blvd Ste 200, Eagle River, AK 99577-7780 | |
| (907) 696-5678 | |
| (907) 696-2248 |
| Full Name | Elysia Peterson |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 6 Years |
| Location | 11470 Business Blvd Ste 200, Eagle River, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073078275 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT6597 (Mississippi) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nor-alaska Physical Therapy, Llc | 7214211036 | 5 |
News Archive
Oncolytics Biotech Inc. announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center in San Antonio (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with gemcitabine (Gemzar(R)) in patients with advanced pancreatic cancer. The Principal Investigator is Dr. Monica Mita of the CTRC.
A team of scientists from Spain has recently evaluated the immune responses induced by mRNA-based Pfizer/BioNTech coronavirus disease 2019 (COVID-19) vaccine in healthcare workers with or without a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Today, the Centers for Disease Control and Prevention (CDC) is issuing Orders to implement the new travel policy announced by the Biden administration to safely resume global travel to the United States while protecting the health and safety of American communities from COVID-19.
Children who possess a gene known to increase the risk of Alzheimer's disease already show signs of reduced cognitive function, an Oregon Health & Science University study has found.
› Verified 1 days ago
| Provider Name | Nor-alaska Physical Therapy, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1326586348 PECOS PAC ID: 7214211036 Enrollment ID: O20170222002922 |
News Archive
Oncolytics Biotech Inc. announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center in San Antonio (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with gemcitabine (Gemzar(R)) in patients with advanced pancreatic cancer. The Principal Investigator is Dr. Monica Mita of the CTRC.
A team of scientists from Spain has recently evaluated the immune responses induced by mRNA-based Pfizer/BioNTech coronavirus disease 2019 (COVID-19) vaccine in healthcare workers with or without a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Today, the Centers for Disease Control and Prevention (CDC) is issuing Orders to implement the new travel policy announced by the Biden administration to safely resume global travel to the United States while protecting the health and safety of American communities from COVID-19.
Children who possess a gene known to increase the risk of Alzheimer's disease already show signs of reduced cognitive function, an Oregon Health & Science University study has found.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elysia Peterson, PT 11470 Business Blvd Ste 200, Eagle River, AK 99577-7780 Ph: (907) 696-5678 | Elysia Peterson, PT 11470 Business Blvd Ste 200, Eagle River, AK 99577-7780 Ph: (907) 696-5678 |
News Archive
Oncolytics Biotech Inc. announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center in San Antonio (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with gemcitabine (Gemzar(R)) in patients with advanced pancreatic cancer. The Principal Investigator is Dr. Monica Mita of the CTRC.
A team of scientists from Spain has recently evaluated the immune responses induced by mRNA-based Pfizer/BioNTech coronavirus disease 2019 (COVID-19) vaccine in healthcare workers with or without a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Today, the Centers for Disease Control and Prevention (CDC) is issuing Orders to implement the new travel policy announced by the Biden administration to safely resume global travel to the United States while protecting the health and safety of American communities from COVID-19.
Children who possess a gene known to increase the risk of Alzheimer's disease already show signs of reduced cognitive function, an Oregon Health & Science University study has found.
› Verified 1 days ago
Jennifer Trebon, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 11432 Business Blvd Ste 18, Eagle River, AK 99577 Phone: 907-622-6363 Fax: 907-622-6366 | |
Danielle Maynard, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 17101 Snowmobile Ln Ste 202, Eagle River, AK 99577 Phone: 907-694-8085 | |
Mildred Margaret Vandergon, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 12103 Horseshoe Dr, Suite B, Eagle River, AK 99577 Phone: 907-696-3657 Fax: 907-622-3657 | |
Melanie Britt Michaels, MPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 10421 Vfw Rd, Suite 103, Eagle River, AK 99577 Phone: 907-350-3657 | |
Julie Marie Parantala, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 12032 Business Blvd, Eagle River, AK 99577 Phone: 907-694-5515 | |
Eagle Center Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 11470 Business Blvd # 200, Eagle River, AK 99577 Phone: 907-696-5678 |